Money for Autism diagnosis?
By Martha Rosenberg, AlterNet. Posted October 19, 2008.Certain antipsychotics are leaving legions of children and elderly in chemical straightjackets for treatment of conditions they didn't even have.
A quote from this Article
"Though atypical antipsychotics were developed to treat schizophrenia and later approved for bipolar disorder (Risperdal is also approved for autism-related irritability in children), pharma lost no time in marketing them for non-FDA-approved uses like ADHD and conduct disorders, dementia, sleep disorders, depression and simple mood swings, netting $8,000 a year per person, usually from state coffers."
NO WONDER OLD WORKING AUTISM LIKE WE HAVE FIGRURED OUT IS IGNORED! Rich Shull on the blog Pre Rain Man Autism .